ALL ARTICLES AND PRODUCT INFORMATION PROVIDED ON THIS WEBSITE ARE FOR INFORMATIONAL AND EDUCATIONAL PURPOSES ONLY. The products offered on this website are intended solely for research and laboratory use. These products are not intended for human or animal consumption. They are not medicines or drugs and have not been evaluated or approved by the FDA to diagnose, treat, cure, or prevent any disease or medical condition. Any form of bodily introduction is strictly prohibited by law.
Ipamorelin 5mg is a selective growth hormone secretagogue known for its potency and safety profile. It is synthesized using the latest technological advancements, ensuring high purity and efficacy for comprehensive research applications.
Ipamorelin 5mg is highly appreciated in the scientific community for its role in growth hormone research, offering valuable insights into endocrine function and potential therapeutic applications.
| CAS No. | 170851-70-4 |
|---|---|
| Purity | ≥99% |
| Sequence | Aib-His-D-2Nal-D-Phe-Lys-NH2 |
| Molecular Formula | C38H49N9O5 |
| Molecular Weight | 711.85 g/mol |
| Synthesis | Solid-phase synthesis |
| Format | Lyophilized powder |
| Solubility | Soluble in water or 1% acetic acid |
| Stability & Storage | Stable for up to 24 months at -20°C. After reconstitution, may be stored at 4°C for up to 4 weeks or at -20°C for up to 6 months. |
| Applications | Growth hormone release studies, muscle growth research, body composition improvement |
| Appearance | White lyophilized powder |
| Shipping Conditions | Shipped at ambient temperature; once received, store at -20°C |
| Regulatory/Compliance | Manufactured in a facility that adheres to cGMP guidelines |
| Safety Information | Refer to provided MSDS |
Consider these supplementary peptides for a comprehensive research approach.
Researchers searching for buy Ipamorelin online should evaluate Ipamorelin as a research-use-only laboratory material, not a consumer product. For laboratory buyers, the key considerations are compound identity, purity documentation, batch-specific COAs, lot traceability, product labeling, and storage information. This guide explains how to evaluate Ipamorelin for controlled research procurement through Pure Lab Peptides, including supplier transparency and documentation review before research acquisition decisions.
Researchers can buy Ipamorelin online for laboratory research by reviewing RUO labeling, batch-specific COA documentation, purity data, identity information, storage guidance, and supplier transparency before selecting a source. Products discussed in this article are intended for laboratory research use only and are not intended for human or animal consumption.
The phrase “buy Ipamorelin online” is addressed here as laboratory research procurement intent, not personal-use intent. In a research context, the query is best understood as a request to compare research-use-only sourcing, documentation quality, analytical transparency, and supplier language.
Qualified researchers, laboratory buyers, research institutions, and technical procurement teams should evaluate whether Ipamorelin is presented as an RUO research compound, whether the supplier provides batch-specific documentation, and whether the product page avoids claims that would shift the material into human-use, animal-use, therapeutic, diagnostic, wellness, or consumer positioning.
Documentation review should include the Ipamorelin COA, product name, lot number, stated purity, testing method, identity testing, storage information, product form, and supplier documentation. A research-use-only procurement decision is strongest when label language, COA data, and lot-level traceability all align.
Ipamorelin is identified in PubChem as a peptide compound with the molecular formula C38H49N9O5, molecular weight of approximately 711.9 g/mol, CAS number 170851-70-4, and the sequence Aib-His-D-2-Nal-D-Phe-Lys-NH2 [1]. The NCI Drug Dictionary also describes Ipamorelin as a pentapeptide and ghrelin mimetic associated with the ghrelin receptor, also known as the growth hormone secretagogue receptor [2].
Database records are useful for research procurement because they give laboratories a neutral identity baseline before comparing vendor documentation. ChEMBL lists Ipamorelin under CHEMBL58547 and cross-references external compound resources, while the FDA Global Substance Registration System associates Ipamorelin with the UNII Y9M3S784Z6 [3] [4]. Researchers should compare these public identity records with the product name, sequence, molecular weight, and lot-specific analytical data supplied by the vendor.
Published literature has characterized Ipamorelin within the growth-hormone secretagogue research category. A 1998 European Journal of Endocrinology paper described Ipamorelin as a selective growth hormone secretagogue in experimental settings [5]. That classification provides scientific context, but it does not create product-use guidance for RUO material.
The broader pathway context includes the growth hormone secretagogue receptor. Howard and colleagues reported a receptor in pituitary and hypothalamic tissue involved in growth hormone release, and Kojima and colleagues later identified ghrelin as an acylated peptide ligand in this research area [6] [7]. Reviews and database entries describe GHSR as a G protein-coupled receptor, and receptor databases such as UniProt and the IUPHAR/BPS Guide to Pharmacology provide additional nomenclature and target context [8] [9] [10].
Pathway relevance in published literature does not establish product-use guidance for RUO materials. In procurement terms, Ipamorelin should be evaluated as an Ipamorelin research material through identity confirmation, purity documentation, batch-specific COA review, and RUO supplier transparency.
Researchers may search “buy Ipamorelin online” when they need to identify whether an RUO supplier presents Ipamorelin with clear product labeling, consistent compound identity, accessible COA documentation, and transparent purity information. The commercial search phrase does not need to imply personal use; it can reflect a technical procurement workflow for qualified laboratories.
When a laboratory team decides where to buy Ipamorelin, the review should focus on product availability, lot-level documentation, supplier language, stated product form, shipping and storage information, and whether documentation can be retained in laboratory records. The search should also include checks for Ipamorelin purity documentation, Ipamorelin identity testing, Ipamorelin supplier documentation, and product page consistency.
A supplier that emphasizes RUO positioning, batch-specific COA access, and analytical method transparency is more aligned with research procurement than a supplier that frames Ipamorelin around outcomes, personal protocols, or unsupported claims.
Researchers evaluating where to buy Ipamorelin online should prioritize quality signals that can be documented, compared, and retained. FDA RUO guidance in the IVD context emphasizes that RUO labeling must align with intended use, and 21 CFR 809.10 describes the RUO statement for products in the laboratory research phase of development in that regulatory setting [11] [12]. Although peptide research materials are not the same as IVDs, the same documentation principle is relevant: labeling, intended use, and supplier claims should be consistent.
| Evaluation Area | What Researchers Should Review | Why It Matters for RUO Procurement |
| RUO labeling | Confirm the product is clearly labeled for research use only | Helps separate research procurement from human-use positioning |
| COA availability | Review batch-specific certificate of analysis | Supports lot-level documentation and quality review |
| Purity data | Look for analytical support for the stated purity | Helps evaluate material consistency |
| Identity testing | Review HPLC, LC-MS, mass spectrometry, or related identity data where available | Helps confirm the material matches the listed compound |
| Lot traceability | Match lot numbers across product and documentation | Supports research recordkeeping |
| Product form | Confirm whether the material is supplied as lyophilized powder or another documented form | Supports laboratory planning |
| Storage information | Review storage and handling documentation | Helps maintain material integrity in laboratory settings |
| Supplier language | Confirm the supplier avoids dosing, therapeutic, or personal-use claims | Supports research-use-only positioning |
COA review should be treated as a documentation workflow, not a box-checking exercise. FDA labeling resources for IVDs distinguish research labeling from diagnostic positioning, and that distinction illustrates why research procurement teams should review intended-use language, labels, and documentation together [13]. For Ipamorelin research-use-only materials, laboratories should verify the compound name, lot number, test date, purity percentage, testing method, identity confirmation, molecular weight, sequence, chromatogram or mass data where available, product form, and storage information.
Analytical method quality matters. FDA adoption of ICH Q2(R2) describes a general framework for analytical procedure validation, while FDA adoption of ICH Q14 describes science- and risk-based analytical procedure development [14] [15]. In peptide analysis, HPLC has long been used for peptide separation and purification, while mass spectrometry is widely used for peptide and protein characterization [16] [17] [18].
A purity percentage alone does not establish complete compound identity; researchers should evaluate purity, identity, method, lot number, and documentation together. Peptide impurity literature shows why LC-MS and related approaches can be important when characterizing structurally related peptide materials and degradation products [19] [20]. Storage documentation should also be recorded because stability guidance frameworks emphasize that storage conditions are part of material quality planning [21]. If outside testing laboratories are involved, ISO/IEC 17025 is a relevant competence framework for testing and calibration laboratories [22].
Ipamorelin appears in literature related to growth-hormone secretagogue receptor research, ghrelin-mimetic compounds, peptide pharmacology, preclinical models, and limited human study settings. The literature should be read as scientific context, not as procurement proof that any RUO lot is suitable for a particular experimental design.
A pharmacokinetic-pharmacodynamic modeling paper examined Ipamorelin in human volunteers, while ClinicalTrials.gov lists clinical study activity involving Ipamorelin in gastrointestinal-function research settings [23] [24]. A later peer-reviewed clinical publication reported a randomized proof-of-concept study in bowel-resection patients [25]. Published clinical literature should not be interpreted as use guidance for RUO materials.
The procurement implication is narrow: published literature can help researchers understand nomenclature, compound class, receptor context, and the types of models in which Ipamorelin has been discussed. It cannot replace COA review, identity testing, purity documentation, lot traceability, or RUO supplier documentation for a specific laboratory material.
Evidence limitations should be stated clearly. Literature may describe database identity, receptor biology, analytical techniques, preclinical investigations, or clinical research settings. Those findings do not convert an Ipamorelin research-use-only product into a clinical, diagnostic, veterinary, therapeutic, supplement, wellness, or personal-use material.
| Research Area | What Literature Examines | Evidence Type | RUO Interpretation |
| Compound identity | Molecular structure, sequence, formula, synonyms, and classification | Database / analytical | Supports identification, not product-use claims |
| Pathway or category context | Ghrelin receptor and growth-hormone secretagogue research context | Review / in vitro / preclinical | Useful for research context, not therapeutic claims |
| Analytical testing | Purity, identity, and batch verification | HPLC / LC-MS / mass spectrometry / COA | Supports documentation review |
| Storage and stability | Material form and handling considerations | Laboratory documentation | Supports research workflow planning |
| Research-Safe Statement | Why It Is Acceptable | Non-Compliant Version to Avoid |
| “Ipamorelin is discussed in published research related to growth-hormone secretagogue receptor pathways.” | Describes literature context without making a product claim | “Ipamorelin helps with human outcomes.” |
| “Researchers should review COA and identity data before procurement.” | Focuses on documentation and quality review | “Users should buy Ipamorelin for results.” |
| “Pure Lab Peptides supplies Ipamorelin as a research-use-only material.” | Clarifies intended use | “Pure Lab Peptides supplies Ipamorelin for therapy.” |
| “The phrase buy Ipamorelin online is addressed as research procurement intent.” | Qualifies commercial search intent | “Buy Ipamorelin online for personal use.” |
| “Ipamorelin supplier documentation should include lot-level identity and purity review.” | Centers the procurement standard on records | “Supplier claims can replace analytical documentation.” |
Pure Lab Peptides presents Ipamorelin 5mg research-use-only product details as laboratory research material. The product is supplied as lyophilized powder, carries a ≥99% purity claim, and has a batch-specific COA available for documentation review. Researchers should review the product page for RUO labeling, product details, purity information, and batch-specific documentation.
For procurement records, the Ipamorelin COA should be matched against the product label and lot information. The review should include stated product identity, product form, storage and handling documentation, lot-level traceability, and supplier transparency. Research teams comparing peptide materials may also review the broader Pure Lab Peptides research peptide collection, educational resources at Pure Lab Peptides blogs, and operational information at shipping and returns.
Pure Lab Peptides should be evaluated on the same research procurement criteria as any RUO source: clear labeling, available batch-specific documentation, consistent compound identity, transparent purity documentation, lot traceability, and avoidance of non-RUO claims.
Buy Ipamorelin online should not be interpreted as personal-use guidance on this page. The phrase is addressed as laboratory procurement intent for qualified researchers reviewing RUO labeling, documentation, purity data, identity information, and supplier transparency.
Published literature can describe compound class, receptor context, analytical methods, or model-specific research. It does not provide instructions for using an RUO material, and it does not validate a specific lot. Researchers should separate literature review from batch-specific documentation review.
Purity percentage is only one documentation element. For Ipamorelin identity testing, researchers should also review the compound name, sequence, molecular weight, analytical method, lot number, chromatographic data, mass data where available, and supplier documentation.
A useful Ipamorelin COA should connect to the specific lot being procured. Batch-specific documentation supports traceability, helps laboratories retain consistent records, and allows product label information to be compared with the certificate of analysis.
RUO labeling does the opposite: it separates laboratory research material from clinical, diagnostic, therapeutic, veterinary, wellness, and consumer use. Researchers should confirm that supplier language stays within research procurement and documentation boundaries.
Researchers can buy Ipamorelin online for laboratory research by reviewing suppliers that provide RUO labeling, batch-specific COA access, identity documentation, purity information, product form details, storage information, and transparent supplier language. Pure Lab Peptides provides an Ipamorelin 5mg product page for research-use-only procurement review.
Before buying Ipamorelin online, researchers should check the product name, RUO label, batch-specific COA, lot number, stated purity, analytical method, identity confirmation, lyophilized powder form, storage documentation, and supplier claims. The supplier should avoid clinical, diagnostic, therapeutic, personal-use, or animal-use positioning.
An Ipamorelin COA matters because it gives procurement teams a batch-specific record for review. A useful COA supports purity documentation, identity testing, lot traceability, and laboratory recordkeeping. Researchers should evaluate the COA together with the product label and supplier documentation.
Ipamorelin discussed on this page is not intended for human or animal consumption. It is addressed only as an Ipamorelin research-use-only material for qualified laboratory settings. The procurement focus is documentation review, not dosing, administration, therapeutic use, diagnostic use, or wellness use.
Research use only means Ipamorelin is positioned as a laboratory research compound for controlled research settings. RUO procurement should involve product identity review, Ipamorelin purity documentation, batch-specific COA review, lot matching, supplier documentation, and storage recordkeeping.
Published literature about Ipamorelin should be interpreted as scientific context for compound identity, receptor research, analytical methods, and research models. It should not be converted into product-use guidance for RUO material. Laboratory teams should rely on batch-specific documentation for procurement decisions.
Qualified researchers evaluating Ipamorelin should review product labeling, COA status, identity documentation, storage information, and supplier transparency. Review the Ipamorelin 5mg product page for RUO labeling, purity information, and available batch-specific documentation.
Our team is ready to assist you with any inquiries regarding our catalogue of peptides and their applications.
Discount Applied Successfully!
Your savings have been added to the cart.
There are no reviews yet.